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Abstracts / International Journal of Surgery 8 (2010) 501–578536Results: 154 (68%) questionnaires were returned. 89% (n ¼ 137) and 84%
(n¼ 130) thought the pre and post biopsy informationwas “just right” and
over 95% (n¼ 148) were either fully or fairly conﬁdent in a CNS performing
their biopsy. 126 patients answered which method they chose to receive
results these choices were 51% (n ¼ 64) letter, 44% (n ¼ 55) telephone a 5%
(n ¼ 6) others. The most common reason for this choice was the desire to
get the result quickly 29% (n¼ 37). Only 18% (n¼ 28) of respondents would
chose to come back to clinic to receive their results.
Conclusions: This study shows that a CNS led prostate biopsy service can
be implemented with a high degree of patient satisfaction. Also patients, if
given the choice, prefer to receive their results by letter or telephone.THE USE OF PSA MEASUREMENT IN THE SETTING OF ACUTE URINARY
RETENTION
T.R. King, B.T. Sherwood, P. Kumar, R.J. Parkinson. Nottingham City
Hospital
Introduction: The use of PSA measurement at the time of presentation
with acute urinary retention (AUR) is a contentious issue. It is widely
considered that AUR itself increases PSA and that the utility of the test in
this setting is limited. Nevertheless, it is commonly applied and interpre-
tation and appropriate response to abnormal results remains a difﬁcult
area.
Patients and Methods: A retrospective study of 100 consecutive patients
presenting with AUR to determine frequency of PSA testing, result inter-
pretation, follow-up strategies and diagnostic yield of prostate cancer.
Results: PSA was measured in 62% of patients and elevated in 67% (mean
PSA 38.7). Of those with elevated PSA, 5 patients had a previous diagnosis
of prostate cancer. 14 were lost to follow up. The remainder underwent
TURP, TRUS biopsy or PSA surveillance. A new diagnosis of prostate cancer
was made in only 2 cases.
Conclusion: PSA testing in patients with AUR is common. Our study
conﬁrms the artifactual rise noted by other authors, and supports the
contention that PSA measurement in this setting should be abandoned.
The diagnostic yield of prostate cancer is low; however this may reﬂect
inadequate assessment.DEVELOPING THE ICIQ-URINARY DIARY: PHASE 1A: EXPLORATORY
PHASE
Elizabeth Bright, Marcus Drake, Paul Abrams. Bristol Urological Institute,
Southmead Hospital, Bristol
Introduction: Despite their common use in urology, there is no stand-
ardised and validated urinary diary (frequency volume chart). The aim of
this study is to produce a validated urinary diary employing the psycho-
metric validation techniques previously used in International Consultation
on Incontinence Questionnaire module development, (www.ICIQ.net).
Phase 1a is the ﬁrst of 3 phases required to produce this diary.
Patients and Methods: Qualitative data gathered through patient inter-
view and clinician-completed questionnaires. Responses from both groups
were coded to identify elements deemed essential for inclusion in the ICIQ
urinary diary.
Results: Patients were interviewed (n ¼ 27) until topic saturation was
achieved. Patients considered frequency, volume voided, ﬂuid intake, ﬂow-
related symptoms, incontinence and bladder sensation as essential items
to include in the diary. Optimal diary duration of ¼ 7 days emerged, butwith no preference for format. 30 clinicians completed the questionnaire
and deemed frequency, volume voided, incontinence and ﬂuid intake as
essential, with optimal diary duration of 3 days, preferably in single sheet
format.
Conclusion: These elements of diary content, duration and format will be
incorporated in a number of draft ICIQ-urinary diaries which will be
subject to tests of content validity in phase 1b to produce the ﬁnal ICIQ-
urinary diary.DOES TEMPORAL ARTERY BIOPSY (TAB) INFLUENCE MANAGEMENT OF
GIANT CELL ARTERITIS (GCA)?
Sarah Cowey, Claire Reynolds, S. Joglekar, J.H. Pereira. James Paget
University Hospital
Introduction: GCA is a form of chronic systemic vasculitis affecting elastic
lamina of medium and large sized arteries commonly affecting the
temporal artery. Clinical symptoms include headaches, jaw claudication,
fever, visual disturbances and joint pains. Based on symptoms, patients are
usually started on steroids to prevent visual loss. Clinical usefulness of TAB
is limited as it often does not inﬂuence management.
Aim: To analyse utility of TAB in inﬂuencing therapeutic decisions.
Methods: Retrospective 8 year case note analysis of patients undergoing
TAB at James Paget Hospital.
Data collected: Age, gender, symptoms, referring physician, pre-op
steroids, biopsy results and post biopsy treatment.
Results: 74 patients were identiﬁed, 14 excluded due to insufﬁcient data.
65%(N ¼ 39) were females and 35%(N ¼ 21) males. The majority Were>50
years (N ¼ 51). 65%(N ¼ 39) were referred via their GP. 66.6% (N ¼ 40)
patients were commenced on steroids before biopsy. 65%(N ¼ 39) had
negative biopsy. 35%(N ¼ 21) had positive biopsy. With negative biopsy
36.5%(N ¼ 15) had steroids discontinued, 48.7%(N ¼ 20) continued on
steroids. 52.4%(N ¼ 36) had an ESR >50.
Conclusion: In our study cohort, only 20%(N ¼ 12) patients were
commenced on steroids based on biopsy results. We therefore, conclude
TAB seldom inﬂuences decisions regarding steroid use.THE COST OF OPEN VS ENDOVASCULAR REPAIR IN EMERGENCY
ABDOMINAL AORTIC ANEURYSMS IN A TERTIRAY CENTRE
Franscois Runau, Mark McCarthy. Leicester Royal Inﬁrmary
Aim: To view the immediate in-patient cost of open versus endovascular
(EVAR) repair in emergency abdominal aortic aneurysm repair.
Methods: Retrospective analysis of patients admitted into our vascular
department with leaking abdominal aortic aneurysm that underwent
either an open repair or EVAR, looking at on-table deaths, 30-daymortality
and average ITU stay.
Results: 213 patients: (174 males, 39 females). 10 received conservative
management. Open repair: 182 patients, 82 patients survived<30 days with
21 on-table deaths. EVAR: 21 patients, 7 patients survived <30 days with 3
on-table deaths. Average ITU length of stay for open repairs: 6 days, EVAR: 2
days (Z 3.098, P value 0.002). Average total hospital stay for open repairs was
15 days and for EVAR was 7.7 days. In our institute, the average cost of
deploying a stent device was £6000, an average ITU bed costs £2149 per
night and an average ward bed costs £408. Average cost of an open repair
including ITU and ward stay amounted to: £16,566 and average cost for an
endovascular repair including ITU and ward stay amounted to: £12,623.60.
